v3.22.4
Consolidated Statements of Changes in Equity
$ in Thousands
USD ($)
shares
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Share capital
USD ($)
shares
Share capital
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
shares
Contributed surplus
USD ($)
Contributed surplus
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Accumulated deficit
USD ($)
Accumulated deficit
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Foreign currency reserve
USD ($)
Foreign currency reserve
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
DSUs
USD ($)
DSUs
Share capital
USD ($)
shares
DSUs
Contributed surplus
USD ($)
RSUs
USD ($)
shares
RSUs
Share capital
USD ($)
shares
RSUs
Contributed surplus
USD ($)
Beginning balance (in shares) at Dec. 31, 2020 | shares     282,078,177                          
Beginning balance at Dec. 31, 2020 $ 900,887   $ 1,884,735   $ 290,761   $ (1,275,516)   $ 907              
Changes in Stock Holders Equity [Roll Forward]                                
Net loss (114,233)           (114,233)                  
Deferred share consideration related to acquisition (notes 7 & 21) 4,851       4,851                      
Equity offerings (in shares) | shares     14,870,000                          
Equity offerings (note 21) $ 527,291   $ 527,291                          
Redeemed/exercised (in shares) | shares 549,281   549,281                 46,388   156,449 156,449  
Redeemed/exercised $ 2,415   $ 3,526   (1,111)           $ (1,290) $ 127 $ (1,417) $ (4,357) $ 577 $ (4,934)
Share-based compensation (note 21) 9,669       9,669           1,290     $ 4,357    
Other comprehensive income (loss):                                
Defined benefit plan actuarial gain (note 20) 2,170           2,170                  
Foreign currency translation for foreign operations 814               814              
Ending balance (in shares) at Dec. 31, 2021 | shares       297,700,295                        
Ending balance at Dec. 31, 2021 1,328,217 $ 1,328,217   $ 2,416,256   $ 297,819   $ (1,387,579)   $ 1,721            
Other comprehensive income (loss):                                
Onerous contracts provision (notes 4 & 18) (1,200)           (1,200)                  
Net loss (173,494)           (173,494)                  
Deferred share consideration related to acquisition (notes 7 & 21) $ (20)   $ 1,762   (1,782)                      
Deferred share consideration related to acquisition (in shares) | shares     112,451                          
Equity offerings (in shares) | shares 112,451                              
Redeemed/exercised (in shares) | shares 304,635   304,635                 58,990   217,832 217,832  
Redeemed/exercised $ 916   $ 1,349   (433)           (753) $ 244 $ (997) $ (2,466) $ 785 $ (3,251)
Share-based compensation (note 21) 9,408       9,408           $ 753     $ 2,466    
Defined benefit plan actuarial gain (note 20) 1,514           1,514                  
Foreign currency translation for foreign operations (3,211)               (3,211)              
Ending balance (in shares) at Dec. 31, 2022 | shares     298,394,203                          
Ending balance at Dec. 31, 2022 1,158,911   $ 2,420,396   $ 300,764   $ (1,560,759)   $ (1,490)              
Other comprehensive income (loss):                                
Onerous contracts provision (notes 4 & 18) $ (4,400)